International Stem Cell Corp.
(OTCQB: ISCO) builds shareholder value through the development of restorative
medicine using stem cell technology. Through its innovative parthenogenesis
technology, the company makes use of human stem cells from unfertilized oocytes
(eggs), bypassing common ethical controversy that accompanies the destruction
of the viable human embryo. Additionally, the company works with subsidiaries
Lifeline Skin Technology and Lifeline Skin Care in the area of skin rejuvenation
on a product that contains a nano-compound that facilitates the replenishment
of the skin’s texture and elasticity.
Evidence of the company’s resolve
to be a leader in the field of restorative medicine can be found in a recent
partnership with The Florey Institute of Neuroscience and Mental Health, one of
the world’s leading brain research centers. The agreement calls for the team to
launch Phase I/IIa clinical trials research on the effects of human
parthenogenetic stem cells in people with Parkinson’s disease.
The credibility The Florey
Institute brings to ISCO’s mission to build shareholder value cannot be
understated. The Florey Institute of Neuroscience and Mental Health is one of
the world’s leading brain research centers, employing a staff of over 500. The
center’s scientists comprise the largest neuroscience research team in
Australia. Its work is conducted on a range of serious diseases, including
stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, traumatic brain and
spinal cord injury, depression, multiple sclerosis, Huntington’s disease, motor
neuron disease, schizophrenia, mental illness and addiction. Further, The
Florey is viewed by many as a world leader in imaging technology, stroke
rehabilitation and epidemiological studies.
The company’s human cell culture
products are made up of adult stem cells and reagents for regenerative medicine
aiding in the study of prostate disease, human renal and bladder diseases,
human corneal cells present in corneal disease and other cell culture reagents
and supplements for the growth, staining, and freezing of human cells. ISCO
markets and sells skincare products through its website, channel sales,
distributors and human cell culture products through its sales force, OEM
partners, and brand distributors. International Stem Cell Corp. was founded in
2001 and is headquartered in Carlsbad, California.
For more information, visit
www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with
companies that have huge potential to succeed in the short and long-term
future. We offer several ways for investors to find, evaluate, and learn more
about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment